Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15817504 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
Conditions: Infant, Premature;   Erythropoietin;   Brain Injury;   Intraventricular Hemorrhage;   Periventricular Leukomalacia;   Neurodevelopmental Outcomes;   Randomized Clinical Trial
Interventions: Drug: Erythropoietin;   Drug: Saline placebo

Indicates status has not been verified in more than two years